Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2017 1
2018 2
2021 2
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Proteomic-based stratification of intermediate-risk prostate cancer patients.
Zhong Q, Sun R, Aref AT, Noor Z, Anees A, Zhu Y, Lucas N, Poulos RC, Lyu M, Zhu T, Chen GB, Wang Y, Ding X, Rutishauser D, Rupp NJ, Rueschoff JH, Poyet C, Hermanns T, Fankhauser C, Rodríguez Martínez M, Shao W, Buljan M, Neumann JF, Beyer A, Hains PG, Reddel RR, Robinson PJ, Aebersold R, Guo T, Wild PJ. Zhong Q, et al. Among authors: rueschoff jh. Life Sci Alliance. 2023 Dec 4;7(2):e202302146. doi: 10.26508/lsa.202302146. Print 2024 Feb. Life Sci Alliance. 2023. PMID: 38052461 Free PMC article.
Single-cell proteomics defines the cellular heterogeneity of localized prostate cancer.
De Vargas Roditi L, Jacobs A, Rueschoff JH, Bankhead P, Chevrier S, Jackson HW, Hermanns T, Fankhauser CD, Poyet C, Chun F, Rupp NJ, Tschaebunin A, Bodenmiller B, Wild PJ. De Vargas Roditi L, et al. Among authors: rueschoff jh. Cell Rep Med. 2022 Apr 19;3(4):100604. doi: 10.1016/j.xcrm.2022.100604. eCollection 2022 Apr 19. Cell Rep Med. 2022. PMID: 35492239 Free PMC article.
68Ga-PSMA-11 PET/MRI versus multiparametric MRI in men referred for prostate biopsy: primary tumour localization and interreader agreement.
Ferraro DA, Hötker AM, Becker AS, Mebert I, Laudicella R, Baltensperger A, Rupp NJ, Rueschoff JH, Müller J, Mortezavi A, Sapienza MT, Eberli D, Donati OF, Burger IA. Ferraro DA, et al. Among authors: rueschoff jh. Eur J Hybrid Imaging. 2022 Jul 18;6(1):14. doi: 10.1186/s41824-022-00135-4. Eur J Hybrid Imaging. 2022. PMID: 35843966 Free PMC article.
Hot needles can confirm accurate lesion sampling intraoperatively using [18F]PSMA-1007 PET/CT-guided biopsy in patients with suspected prostate cancer.
Ferraro DA, Laudicella R, Zeimpekis K, Mebert I, Müller J, Maurer A, Grünig H, Donati O, Sapienza MT, Rueschoff JH, Rupp N, Eberli D, Burger IA. Ferraro DA, et al. Among authors: rueschoff jh. Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1721-1730. doi: 10.1007/s00259-021-05599-3. Epub 2021 Nov 2. Eur J Nucl Med Mol Imaging. 2022. PMID: 34725726 Free PMC article.
Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study.
Ferraro DA, Becker AS, Kranzbühler B, Mebert I, Baltensperger A, Zeimpekis KG, Grünig H, Messerli M, Rupp NJ, Rueschoff JH, Mortezavi A, Donati OF, Sapienza MT, Eberli D, Burger IA. Ferraro DA, et al. Among authors: rueschoff jh. Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3315-3324. doi: 10.1007/s00259-021-05261-y. Epub 2021 Feb 23. Eur J Nucl Med Mol Imaging. 2021. PMID: 33620559 Free PMC article.
Improving the turnaround time of molecular profiling for advanced non-small cell lung cancer: Outcome of a new algorithm integrating multiple approaches.
Treichler G, Hoeller S, Rueschoff JH, Rechsteiner M, Britschgi C, Arnold F, Zoche M, Hiltbrunner S, Moch H, Akhoundova D, Opitz I, Curioni-Fontecedro A. Treichler G, et al. Among authors: rueschoff jh. Pathol Res Pract. 2023 Aug;248:154660. doi: 10.1016/j.prp.2023.154660. Epub 2023 Jul 1. Pathol Res Pract. 2023. PMID: 37413876 Free article.